Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGAV | P06756 | 20/20 | 0.74 |
| ▸ | ITGB3 | P05106 | 9/20 | 0.74 |
| ▸ | ITGB6 | P18564 | 11/20 | 0.53 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.48 |
| ▸ | ITGA4 | P13612 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21314532 | 0.87 | ITGAV (0.75) | ITGAVITGB3ITGB6ITGB1ITGA4 | |
| SCHEMBL21314431 | 0.87 | ITGAV (0.75) | ITGAVITGB3ITGB6ITGB1ITGA4 | |
| SCHEMBL6421342 | 0.85 | ITGAV (1.00) | ITGAVITGB3ITGB6 | |
| SCHEMBL6421344 | 0.85 | ITGAV (1.00) | ITGAVITGB3ITGB6 | |
| SCHEMBL23747194 | 0.81 | ITGAV (0.76) | ITGAVITGB3ITGB6ITGB1ITGA4 | |
| SCHEMBL22029457 | 0.81 | ITGAV (0.85) | ITGAVITGB3ITGB6ITGB1ITGA4 | |
| SCHEMBL22029456 | 0.81 | ITGAV (0.85) | ITGAVITGB3ITGB6ITGB1ITGA4 | |
| SCHEMBL22029471 | 0.81 | ITGAV (0.85) | ITGAVITGB3ITGB6ITGB1ITGA4 | |
| SCHEMBL30487509 | 0.80 | ITGAV (0.65) | ITGAVITGB3ITGB6ITGB1ITGA4 | |
| SCHEMBL24362786 | 0.79 | ITGAV (0.78) | ITGAVITGB3ITGB6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3538526-A1 | CYCLOBUTANE- AND AZETIDINE-CONTAINING MONO AND SPIROCYCLIC COMPOUNDS AS ALPHA V INTEGRIN INHIBITORS | Bristol-Myers Squibb Company (US) | 2019-09-18 | — | — | EP | disclosed |
| WO-2018089355-A1 | CYCLOBUTANE- AND AZETIDINE-CONTAINING MONO AND SPIROCYCLIC COMPOUNDS AS ALPHA V INTEGRIN INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2018-05-17 | — | — | WO | disclosed |